HEADER TRANSCRIPTION 02-JUN-04 1TIL TITLE CRYSTAL STRUCTURES OF THE ADP AND ATP BOUND FORMS OF THE BACILLUS TITLE 2 ANTI-SIGMA FACTOR SPOIIAB IN COMPLEX WITH THE ANTI-ANTI-SIGMA TITLE 3 SPOIIAA:POISED FOR PHOSPHORYLATION COMPLEX WITH ATP, CRYSTAL FORM II COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTI-SIGMA F FACTOR; COMPND 3 CHAIN: A, C, E; COMPND 4 SYNONYM: STAGE II SPORULATION PROTEIN AB; COMPND 5 EC: 2.7.1.37; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: ANTI-SIGMA F FACTOR ANTAGONIST; COMPND 10 CHAIN: B, D, F; COMPND 11 SYNONYM: STAGE II SPORULATION PROTEIN AA; COMPND 12 ENGINEERED: YES; COMPND 13 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GEOBACILLUS STEAROTHERMOPHILUS; SOURCE 3 ORGANISM_TAXID: 1422; SOURCE 4 GENE: SPOIIAB; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET21A; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: GEOBACILLUS STEAROTHERMOPHILUS; SOURCE 12 ORGANISM_TAXID: 1422; SOURCE 13 GENE: SPOIIAA; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PET21A KEYWDS SPOIIAB, SPOIIA, ANTI-SIGMA, ANTI-ANTI-SIGMA, SPORULATION, SERINE KEYWDS 2 KINASEA, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR S.MASUDA,K.S.MURAKAMI,S.WANG,C.A.OLSON,J.DONIGAN,F.LEON,S.A.DARST, AUTHOR 2 E.A.CAMPBELL REVDAT 4 27-OCT-21 1TIL 1 REMARK SEQADV LINK REVDAT 3 24-FEB-09 1TIL 1 VERSN REVDAT 2 20-JUL-04 1TIL 1 JRNL REVDAT 1 15-JUN-04 1TIL 0 JRNL AUTH S.MASUDA,K.S.MURAKAMI,S.WANG,C.A.OLSON,J.DONIGIAN,F.LEON, JRNL AUTH 2 S.A.DARST,E.A.CAMPBELL JRNL TITL CRYSTAL STRUCTURES OF THE ADP AND ATP BOUND FORMS OF THE JRNL TITL 2 BACILLUS ANTI-SIGMA FACTOR SPOIIAB IN COMPLEX WITH THE JRNL TITL 3 ANTI-ANTI-SIGMA SPOIIAA. JRNL REF J.MOL.BIOL. V. 340 941 2004 JRNL REFN ISSN 0022-2836 JRNL PMID 15236958 JRNL DOI 10.1016/J.JMB.2004.05.040 REMARK 2 REMARK 2 RESOLUTION. 2.70 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 97.6 REMARK 3 NUMBER OF REFLECTIONS : 51695 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.234 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 2585 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5997 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 96 REMARK 3 SOLVENT ATOMS : 155 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1TIL COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-JUN-04. REMARK 100 THE DEPOSITION ID IS D_1000022665. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-MAR-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.6 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51695 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.6 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.01000 REMARK 200 FOR THE DATA SET : 12.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 88.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.40000 REMARK 200 FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY ID 1L0O, PDB ENTRY ID 1H4Y REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 74.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.84 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1 M SODIUM CITRATE, 0.42 M AMMONIUM REMARK 280 SULFATE, 1.0 M LITHIUM SULFATE, PH 5.6, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 295.5K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 5555 -X,Y,-Z REMARK 290 6555 X,-Y,-Z+1/2 REMARK 290 7555 Y,X,-Z+3/4 REMARK 290 8555 -Y,-X,-Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 128.41000 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 64.20500 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 192.61500 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 128.41000 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 192.61500 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 64.20500 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSSEMBLY OF 2AB/2AA (A TETRAMER) IS REMARK 300 COMPOSED BY CHAINS A, B, C AND D. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7220 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -47.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 128.41000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 LYS A 142 REMARK 465 ALA A 143 REMARK 465 LEU A 144 REMARK 465 SER A 145 REMARK 465 ASN A 146 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 LYS C 142 REMARK 465 ALA C 143 REMARK 465 LEU C 144 REMARK 465 SER C 145 REMARK 465 ASN C 146 REMARK 465 GLY D -2 REMARK 465 SER E 141 REMARK 465 LYS E 142 REMARK 465 ALA E 143 REMARK 465 LEU E 144 REMARK 465 SER E 145 REMARK 465 ASN E 146 REMARK 465 GLY F -2 REMARK 465 SER F -1 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 HIS B 0 CG ND1 CD2 CE1 NE2 REMARK 470 SER C 141 OG REMARK 470 SER D -1 OG REMARK 470 HIS D 0 CG ND1 CD2 CE1 NE2 REMARK 470 MET D 1 CG SD CE REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 31 69.76 35.21 REMARK 500 PRO A 60 -3.71 -58.89 REMARK 500 GLU A 82 54.14 -99.00 REMARK 500 LEU A 96 -5.98 67.43 REMARK 500 LYS A 100 55.82 -141.61 REMARK 500 ASN A 127 -3.90 74.49 REMARK 500 LYS A 136 117.98 -177.24 REMARK 500 SER B 2 10.93 53.19 REMARK 500 GLN B 11 88.14 8.10 REMARK 500 ASP B 57 -167.49 -114.16 REMARK 500 ILE B 99 -74.58 -86.14 REMARK 500 VAL B 115 -75.83 -55.86 REMARK 500 ARG C 2 59.32 -154.10 REMARK 500 GLU C 71 114.54 -171.68 REMARK 500 GLU C 82 52.10 -94.09 REMARK 500 LEU C 96 -9.81 82.07 REMARK 500 LYS C 128 -59.28 -142.09 REMARK 500 VAL C 139 108.04 -53.99 REMARK 500 HIS D 0 164.41 168.12 REMARK 500 GLN D 11 79.96 24.69 REMARK 500 ASP D 12 3.58 80.48 REMARK 500 GLN D 52 32.04 -89.92 REMARK 500 ASN D 73 14.87 -68.94 REMARK 500 ALA D 104 -88.81 -54.37 REMARK 500 ARG E 2 139.60 -178.77 REMARK 500 ASN E 3 140.02 177.44 REMARK 500 ASN E 15 9.82 -62.29 REMARK 500 GLN E 29 8.02 -59.56 REMARK 500 HIS E 54 -65.79 -91.27 REMARK 500 ASN E 58 18.26 58.77 REMARK 500 GLU E 71 116.39 -173.22 REMARK 500 GLU E 82 40.42 -102.32 REMARK 500 LEU E 96 -5.37 81.32 REMARK 500 LEU E 103 49.99 -102.01 REMARK 500 GLU E 104 52.14 28.22 REMARK 500 GLU E 119 127.96 -175.99 REMARK 500 ASN E 127 -11.30 72.42 REMARK 500 LYS E 128 -71.82 -84.00 REMARK 500 MET F 1 -112.32 -96.06 REMARK 500 GLN F 11 81.53 32.07 REMARK 500 ASP F 12 -2.19 78.13 REMARK 500 ALA F 42 71.11 -106.41 REMARK 500 ASP F 57 -167.22 -119.37 REMARK 500 ASN F 73 8.11 -63.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 300 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 50 OD1 REMARK 620 2 ASN A 50 ND2 47.2 REMARK 620 3 ATP A 200 O1A 75.3 62.4 REMARK 620 4 ATP A 200 O2G 139.2 164.2 103.2 REMARK 620 5 ATP A 200 O1B 74.2 112.9 75.3 66.3 REMARK 620 N 1 2 3 4 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG C 301 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN C 50 OD1 REMARK 620 2 ATP C 201 O2G 154.1 REMARK 620 3 ATP C 201 O1A 76.4 111.6 REMARK 620 4 ATP C 201 O1B 84.8 73.5 78.0 REMARK 620 N 1 2 3 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG E 302 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN E 50 OD1 REMARK 620 2 ATP E 202 O1B 76.0 REMARK 620 3 ATP E 202 O1A 78.9 80.6 REMARK 620 4 ATP E 202 O2G 137.3 72.9 123.0 REMARK 620 N 1 2 3 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 300 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG C 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG E 302 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP A 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP C 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ATP E 202 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1THN RELATED DB: PDB REMARK 900 INHIBITORY COMPLEX, CRYSTAL FORM I REMARK 900 RELATED ID: 1TH8 RELATED DB: PDB REMARK 900 INHIBITORY COMPLEX, CRYSTAL FOR II REMARK 900 RELATED ID: 1TID RELATED DB: PDB REMARK 900 POISED FOR PHOSPHORYLATION COMPLEX , CRYSTAL FORM I REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE DISCREPANCIES IN BOTH CHAINS ARE DUE TO STRAIN REMARK 999 VARIATION. DBREF 1TIL A 1 146 UNP O32727 SP2AB_BACST 1 136 DBREF 1TIL B 1 116 UNP O32726 SP2AA_BACST 1 116 DBREF 1TIL C 1 146 UNP O32727 SP2AB_BACST 1 136 DBREF 1TIL D 1 116 UNP O32726 SP2AA_BACST 1 116 DBREF 1TIL E 1 146 UNP O32727 SP2AB_BACST 1 136 DBREF 1TIL F 1 116 UNP O32726 SP2AA_BACST 1 116 SEQADV 1TIL MET A 34 UNP O32727 THR 34 SEE REMARK 999 SEQADV 1TIL HIS A 137 UNP O32727 ALA 137 SEE REMARK 999 SEQADV 1TIL ILE A 138 UNP O32727 TYR 138 SEE REMARK 999 SEQADV 1TIL VAL A 139 UNP O32727 CYS 139 SEE REMARK 999 SEQADV 1TIL LYS A 140 UNP O32727 GLU 140 SEE REMARK 999 SEQADV 1TIL SER A 141 UNP O32727 LYS 141 SEE REMARK 999 SEQADV 1TIL LYS A 142 UNP O32727 GLN 142 SEE REMARK 999 SEQADV 1TIL ALA A 143 UNP O32727 THR 143 SEE REMARK 999 SEQADV 1TIL SER A 145 UNP O32727 CYS 145 ENGINEERED MUTATION SEQADV 1TIL MET C 34 UNP O32727 THR 34 SEE REMARK 999 SEQADV 1TIL HIS C 137 UNP O32727 ALA 137 SEE REMARK 999 SEQADV 1TIL ILE C 138 UNP O32727 TYR 138 SEE REMARK 999 SEQADV 1TIL VAL C 139 UNP O32727 CYS 139 SEE REMARK 999 SEQADV 1TIL LYS C 140 UNP O32727 GLU 140 SEE REMARK 999 SEQADV 1TIL SER C 141 UNP O32727 LYS 141 SEE REMARK 999 SEQADV 1TIL LYS C 142 UNP O32727 GLN 142 SEE REMARK 999 SEQADV 1TIL ALA C 143 UNP O32727 THR 143 SEE REMARK 999 SEQADV 1TIL SER C 145 UNP O32727 CYS 145 ENGINEERED MUTATION SEQADV 1TIL MET E 34 UNP O32727 THR 34 SEE REMARK 999 SEQADV 1TIL HIS E 137 UNP O32727 ALA 137 SEE REMARK 999 SEQADV 1TIL ILE E 138 UNP O32727 TYR 138 SEE REMARK 999 SEQADV 1TIL VAL E 139 UNP O32727 CYS 139 SEE REMARK 999 SEQADV 1TIL LYS E 140 UNP O32727 GLU 140 SEE REMARK 999 SEQADV 1TIL SER E 141 UNP O32727 LYS 141 SEE REMARK 999 SEQADV 1TIL LYS E 142 UNP O32727 GLN 142 SEE REMARK 999 SEQADV 1TIL ALA E 143 UNP O32727 THR 143 SEE REMARK 999 SEQADV 1TIL SER E 145 UNP O32727 CYS 145 ENGINEERED MUTATION SEQADV 1TIL GLY B -2 UNP O32726 CLONING ARTIFACT SEQADV 1TIL SER B -1 UNP O32726 CLONING ARTIFACT SEQADV 1TIL HIS B 0 UNP O32726 CLONING ARTIFACT SEQADV 1TIL VAL B 13 UNP O32726 GLU 13 SEE REMARK 999 SEQADV 1TIL GLU B 29 UNP O32726 ASN 29 SEE REMARK 999 SEQADV 1TIL LEU B 30 UNP O32726 CYS 30 SEE REMARK 999 SEQADV 1TIL ARG B 31 UNP O32726 MET 31 SEE REMARK 999 SEQADV 1TIL GLU B 32 UNP O32726 ASN 32 SEE REMARK 999 SEQADV 1TIL GLN B 33 UNP O32726 LYS 33 SEE REMARK 999 SEQADV 1TIL VAL B 34 UNP O32726 CYS 34 SEE REMARK 999 SEQADV 1TIL THR B 35 UNP O32726 ARG 35 SEE REMARK 999 SEQADV 1TIL ASP B 36 UNP O32726 MET 36 SEE REMARK 999 SEQADV 1TIL VAL B 37 UNP O32726 CYS 37 SEE REMARK 999 SEQADV 1TIL ASN B 40 UNP O32726 LYS 40 SEE REMARK 999 SEQADV 1TIL ALA B 58 UNP O32726 SER 58 ENGINEERED MUTATION SEQADV 1TIL GLY D -2 UNP O32726 CLONING ARTIFACT SEQADV 1TIL SER D -1 UNP O32726 CLONING ARTIFACT SEQADV 1TIL HIS D 0 UNP O32726 CLONING ARTIFACT SEQADV 1TIL VAL D 13 UNP O32726 GLU 13 SEE REMARK 999 SEQADV 1TIL GLU D 29 UNP O32726 ASN 29 SEE REMARK 999 SEQADV 1TIL LEU D 30 UNP O32726 CYS 30 SEE REMARK 999 SEQADV 1TIL ARG D 31 UNP O32726 MET 31 SEE REMARK 999 SEQADV 1TIL GLU D 32 UNP O32726 ASN 32 SEE REMARK 999 SEQADV 1TIL GLN D 33 UNP O32726 LYS 33 SEE REMARK 999 SEQADV 1TIL VAL D 34 UNP O32726 CYS 34 SEE REMARK 999 SEQADV 1TIL THR D 35 UNP O32726 ARG 35 SEE REMARK 999 SEQADV 1TIL ASP D 36 UNP O32726 MET 36 SEE REMARK 999 SEQADV 1TIL VAL D 37 UNP O32726 CYS 37 SEE REMARK 999 SEQADV 1TIL ASN D 40 UNP O32726 LYS 40 SEE REMARK 999 SEQADV 1TIL ALA D 58 UNP O32726 SER 58 ENGINEERED MUTATION SEQADV 1TIL GLY F -2 UNP O32726 CLONING ARTIFACT SEQADV 1TIL SER F -1 UNP O32726 CLONING ARTIFACT SEQADV 1TIL HIS F 0 UNP O32726 CLONING ARTIFACT SEQADV 1TIL VAL F 13 UNP O32726 GLU 13 SEE REMARK 999 SEQADV 1TIL GLU F 29 UNP O32726 ASN 29 SEE REMARK 999 SEQADV 1TIL LEU F 30 UNP O32726 CYS 30 SEE REMARK 999 SEQADV 1TIL ARG F 31 UNP O32726 MET 31 SEE REMARK 999 SEQADV 1TIL GLU F 32 UNP O32726 ASN 32 SEE REMARK 999 SEQADV 1TIL GLN F 33 UNP O32726 LYS 33 SEE REMARK 999 SEQADV 1TIL VAL F 34 UNP O32726 CYS 34 SEE REMARK 999 SEQADV 1TIL THR F 35 UNP O32726 ARG 35 SEE REMARK 999 SEQADV 1TIL ASP F 36 UNP O32726 MET 36 SEE REMARK 999 SEQADV 1TIL VAL F 37 UNP O32726 CYS 37 SEE REMARK 999 SEQADV 1TIL ASN F 40 UNP O32726 LYS 40 SEE REMARK 999 SEQADV 1TIL ALA F 58 UNP O32726 SER 58 ENGINEERED MUTATION SEQRES 1 A 146 MET ARG ASN GLU MET HIS LEU GLN PHE SER ALA ARG SER SEQRES 2 A 146 GLU ASN GLU SER PHE ALA ARG VAL THR VAL ALA ALA PHE SEQRES 3 A 146 VAL ALA GLN LEU ASP PRO THR MET ASP GLU LEU THR GLU SEQRES 4 A 146 ILE LYS THR VAL VAL SER GLU ALA VAL THR ASN ALA ILE SEQRES 5 A 146 ILE HIS GLY TYR ASN ASN ASP PRO ASN GLY ILE VAL SER SEQRES 6 A 146 ILE SER VAL ILE ILE GLU ASP GLY VAL VAL HIS LEU THR SEQRES 7 A 146 VAL ARG ASP GLU GLY VAL GLY ILE PRO ASP ILE GLU GLU SEQRES 8 A 146 ALA ARG GLN PRO LEU PHE THR THR LYS PRO GLU LEU GLU SEQRES 9 A 146 ARG SER GLY MET GLY PHE THR ILE MET GLU ASN PHE MET SEQRES 10 A 146 ASP GLU VAL ILE VAL GLU SER GLU VAL ASN LYS GLY THR SEQRES 11 A 146 THR VAL TYR LEU LYS LYS HIS ILE VAL LYS SER LYS ALA SEQRES 12 A 146 LEU SER ASN SEQRES 1 B 119 GLY SER HIS MET SER LEU ALA ILE ASP LEU GLU VAL LYS SEQRES 2 B 119 GLN ASP VAL LEU ILE VAL ARG LEU SER GLY GLU LEU ASP SEQRES 3 B 119 HIS HIS THR ALA GLU GLU LEU ARG GLU GLN VAL THR ASP SEQRES 4 B 119 VAL LEU GLU ASN ARG ALA ILE ARG HIS ILE VAL LEU ASN SEQRES 5 B 119 LEU GLY GLN LEU THR PHE MET ASP ALA SER GLY LEU GLY SEQRES 6 B 119 VAL ILE LEU GLY ARG TYR LYS GLN ILE LYS ASN VAL GLY SEQRES 7 B 119 GLY GLN MET VAL VAL CYS ALA VAL SER PRO ALA VAL LYS SEQRES 8 B 119 ARG LEU PHE ASP MET SER GLY LEU PHE LYS ILE ILE ARG SEQRES 9 B 119 VAL GLU ALA ASP GLU GLN PHE ALA LEU GLN ALA LEU GLY SEQRES 10 B 119 VAL ALA SEQRES 1 C 146 MET ARG ASN GLU MET HIS LEU GLN PHE SER ALA ARG SER SEQRES 2 C 146 GLU ASN GLU SER PHE ALA ARG VAL THR VAL ALA ALA PHE SEQRES 3 C 146 VAL ALA GLN LEU ASP PRO THR MET ASP GLU LEU THR GLU SEQRES 4 C 146 ILE LYS THR VAL VAL SER GLU ALA VAL THR ASN ALA ILE SEQRES 5 C 146 ILE HIS GLY TYR ASN ASN ASP PRO ASN GLY ILE VAL SER SEQRES 6 C 146 ILE SER VAL ILE ILE GLU ASP GLY VAL VAL HIS LEU THR SEQRES 7 C 146 VAL ARG ASP GLU GLY VAL GLY ILE PRO ASP ILE GLU GLU SEQRES 8 C 146 ALA ARG GLN PRO LEU PHE THR THR LYS PRO GLU LEU GLU SEQRES 9 C 146 ARG SER GLY MET GLY PHE THR ILE MET GLU ASN PHE MET SEQRES 10 C 146 ASP GLU VAL ILE VAL GLU SER GLU VAL ASN LYS GLY THR SEQRES 11 C 146 THR VAL TYR LEU LYS LYS HIS ILE VAL LYS SER LYS ALA SEQRES 12 C 146 LEU SER ASN SEQRES 1 D 119 GLY SER HIS MET SER LEU ALA ILE ASP LEU GLU VAL LYS SEQRES 2 D 119 GLN ASP VAL LEU ILE VAL ARG LEU SER GLY GLU LEU ASP SEQRES 3 D 119 HIS HIS THR ALA GLU GLU LEU ARG GLU GLN VAL THR ASP SEQRES 4 D 119 VAL LEU GLU ASN ARG ALA ILE ARG HIS ILE VAL LEU ASN SEQRES 5 D 119 LEU GLY GLN LEU THR PHE MET ASP ALA SER GLY LEU GLY SEQRES 6 D 119 VAL ILE LEU GLY ARG TYR LYS GLN ILE LYS ASN VAL GLY SEQRES 7 D 119 GLY GLN MET VAL VAL CYS ALA VAL SER PRO ALA VAL LYS SEQRES 8 D 119 ARG LEU PHE ASP MET SER GLY LEU PHE LYS ILE ILE ARG SEQRES 9 D 119 VAL GLU ALA ASP GLU GLN PHE ALA LEU GLN ALA LEU GLY SEQRES 10 D 119 VAL ALA SEQRES 1 E 146 MET ARG ASN GLU MET HIS LEU GLN PHE SER ALA ARG SER SEQRES 2 E 146 GLU ASN GLU SER PHE ALA ARG VAL THR VAL ALA ALA PHE SEQRES 3 E 146 VAL ALA GLN LEU ASP PRO THR MET ASP GLU LEU THR GLU SEQRES 4 E 146 ILE LYS THR VAL VAL SER GLU ALA VAL THR ASN ALA ILE SEQRES 5 E 146 ILE HIS GLY TYR ASN ASN ASP PRO ASN GLY ILE VAL SER SEQRES 6 E 146 ILE SER VAL ILE ILE GLU ASP GLY VAL VAL HIS LEU THR SEQRES 7 E 146 VAL ARG ASP GLU GLY VAL GLY ILE PRO ASP ILE GLU GLU SEQRES 8 E 146 ALA ARG GLN PRO LEU PHE THR THR LYS PRO GLU LEU GLU SEQRES 9 E 146 ARG SER GLY MET GLY PHE THR ILE MET GLU ASN PHE MET SEQRES 10 E 146 ASP GLU VAL ILE VAL GLU SER GLU VAL ASN LYS GLY THR SEQRES 11 E 146 THR VAL TYR LEU LYS LYS HIS ILE VAL LYS SER LYS ALA SEQRES 12 E 146 LEU SER ASN SEQRES 1 F 119 GLY SER HIS MET SER LEU ALA ILE ASP LEU GLU VAL LYS SEQRES 2 F 119 GLN ASP VAL LEU ILE VAL ARG LEU SER GLY GLU LEU ASP SEQRES 3 F 119 HIS HIS THR ALA GLU GLU LEU ARG GLU GLN VAL THR ASP SEQRES 4 F 119 VAL LEU GLU ASN ARG ALA ILE ARG HIS ILE VAL LEU ASN SEQRES 5 F 119 LEU GLY GLN LEU THR PHE MET ASP ALA SER GLY LEU GLY SEQRES 6 F 119 VAL ILE LEU GLY ARG TYR LYS GLN ILE LYS ASN VAL GLY SEQRES 7 F 119 GLY GLN MET VAL VAL CYS ALA VAL SER PRO ALA VAL LYS SEQRES 8 F 119 ARG LEU PHE ASP MET SER GLY LEU PHE LYS ILE ILE ARG SEQRES 9 F 119 VAL GLU ALA ASP GLU GLN PHE ALA LEU GLN ALA LEU GLY SEQRES 10 F 119 VAL ALA HET MG A 300 1 HET ATP A 200 31 HET MG C 301 1 HET ATP C 201 31 HET MG E 302 1 HET ATP E 202 31 HETNAM MG MAGNESIUM ION HETNAM ATP ADENOSINE-5'-TRIPHOSPHATE FORMUL 7 MG 3(MG 2+) FORMUL 8 ATP 3(C10 H16 N5 O13 P3) FORMUL 13 HOH *155(H2 O) HELIX 1 1 SER A 13 GLN A 29 1 17 HELIX 2 2 THR A 33 HIS A 54 1 22 HELIX 3 3 ASP A 88 ARG A 93 1 6 HELIX 4 4 LYS A 100 GLU A 104 5 5 HELIX 5 5 MET A 108 MET A 117 1 10 HELIX 6 6 ASP B 23 ARG B 41 1 19 HELIX 7 7 ASP B 57 ASN B 73 1 17 HELIX 8 8 SER B 84 GLY B 95 1 12 HELIX 9 9 ASP B 105 GLY B 114 1 10 HELIX 10 10 SER C 13 ALA C 28 1 16 HELIX 11 11 GLN C 29 ASP C 31 5 3 HELIX 12 12 THR C 33 HIS C 54 1 22 HELIX 13 13 ASP C 88 ARG C 93 1 6 HELIX 14 14 LYS C 100 GLU C 104 5 5 HELIX 15 15 MET C 108 MET C 117 1 10 HELIX 16 16 ASP D 23 ARG D 41 1 19 HELIX 17 17 ASP D 57 ASN D 73 1 17 HELIX 18 18 SER D 84 ASP D 92 1 9 HELIX 19 19 MET D 93 ILE D 100 5 8 HELIX 20 20 ASP D 105 GLY D 114 1 10 HELIX 21 21 GLU E 14 GLN E 29 1 16 HELIX 22 22 THR E 33 HIS E 54 1 22 HELIX 23 23 ASP E 88 ARG E 93 1 6 HELIX 24 24 LYS E 100 GLU E 104 5 5 HELIX 25 25 MET E 108 MET E 117 1 10 HELIX 26 26 ASP F 23 ARG F 41 1 19 HELIX 27 27 ASP F 57 ASN F 73 1 17 HELIX 28 28 SER F 84 ASP F 92 1 9 HELIX 29 29 MET F 93 ILE F 100 5 8 HELIX 30 30 ASP F 105 LEU F 113 1 9 SHEET 1 A10 GLU A 119 GLU A 125 0 SHEET 2 A10 GLY A 129 HIS A 137 -1 O TYR A 133 N ILE A 121 SHEET 3 A10 VAL A 74 ASP A 81 -1 N LEU A 77 O LEU A 134 SHEET 4 A10 ILE A 63 GLU A 71 -1 N SER A 65 O ARG A 80 SHEET 5 A10 ARG A 2 SER A 10 -1 N LEU A 7 O ILE A 66 SHEET 6 A10 GLU C 4 SER C 10 -1 O GLN C 8 N HIS A 6 SHEET 7 A10 ILE C 63 GLU C 71 -1 O ILE C 66 N LEU C 7 SHEET 8 A10 VAL C 74 ASP C 81 -1 O ARG C 80 N SER C 65 SHEET 9 A10 GLY C 129 HIS C 137 -1 O VAL C 132 N VAL C 79 SHEET 10 A10 GLU C 119 GLU C 125 -1 N GLU C 123 O THR C 131 SHEET 1 B 5 LEU B 3 LYS B 10 0 SHEET 2 B 5 VAL B 13 LEU B 22 -1 O VAL B 13 N LYS B 10 SHEET 3 B 5 HIS B 45 MET B 56 1 O ASN B 49 N VAL B 16 SHEET 4 B 5 MET B 78 CYS B 81 1 O VAL B 79 N LEU B 48 SHEET 5 B 5 ARG B 101 GLU B 103 1 O GLU B 103 N VAL B 80 SHEET 1 C 5 LEU D 3 LYS D 10 0 SHEET 2 C 5 VAL D 13 LEU D 22 -1 O ILE D 15 N GLU D 8 SHEET 3 C 5 HIS D 45 MET D 56 1 O ASN D 49 N VAL D 16 SHEET 4 C 5 GLN D 77 CYS D 81 1 O CYS D 81 N LEU D 48 SHEET 5 C 5 ARG D 101 GLU D 103 1 O ARG D 101 N VAL D 80 SHEET 1 D 5 ASN E 3 SER E 10 0 SHEET 2 D 5 ILE E 63 GLU E 71 -1 O ILE E 66 N LEU E 7 SHEET 3 D 5 VAL E 74 ASP E 81 -1 O ARG E 80 N SER E 65 SHEET 4 D 5 GLY E 129 HIS E 137 -1 O LEU E 134 N LEU E 77 SHEET 5 D 5 GLU E 119 GLU E 125 -1 N GLU E 123 O THR E 131 SHEET 1 E 5 LEU F 3 LYS F 10 0 SHEET 2 E 5 VAL F 13 LEU F 22 -1 O SER F 19 N ALA F 4 SHEET 3 E 5 HIS F 45 MET F 56 1 O THR F 54 N GLY F 20 SHEET 4 E 5 MET F 78 CYS F 81 1 O CYS F 81 N LEU F 48 SHEET 5 E 5 ARG F 101 GLU F 103 1 O ARG F 101 N VAL F 80 LINK OD1 ASN A 50 MG MG A 300 1555 1555 2.06 LINK ND2 ASN A 50 MG MG A 300 1555 1555 3.06 LINK O1A ATP A 200 MG MG A 300 1555 1555 2.93 LINK O2G ATP A 200 MG MG A 300 1555 1555 2.27 LINK O1B ATP A 200 MG MG A 300 1555 1555 2.97 LINK OD1 ASN C 50 MG MG C 301 1555 1555 2.19 LINK O2G ATP C 201 MG MG C 301 1555 1555 1.98 LINK O1A ATP C 201 MG MG C 301 1555 1555 2.66 LINK O1B ATP C 201 MG MG C 301 1555 1555 2.88 LINK OD1 ASN E 50 MG MG E 302 1555 1555 2.05 LINK O1B ATP E 202 MG MG E 302 1555 1555 2.88 LINK O1A ATP E 202 MG MG E 302 1555 1555 2.80 LINK O2G ATP E 202 MG MG E 302 1555 1555 2.44 SITE 1 AC1 3 GLU A 46 ASN A 50 ATP A 200 SITE 1 AC2 3 GLU C 46 ASN C 50 ATP C 201 SITE 1 AC3 4 GLU E 46 ASN E 50 GLY E 109 ATP E 202 SITE 1 AC4 24 GLU A 46 ASN A 50 ALA A 51 HIS A 54 SITE 2 AC4 24 GLY A 55 ASP A 81 GLY A 85 ILE A 86 SITE 3 AC4 24 ALA A 92 THR A 98 THR A 99 ARG A 105 SITE 4 AC4 24 SER A 106 GLY A 107 MET A 108 GLY A 109 SITE 5 AC4 24 PHE A 110 THR A 130 MG A 300 HOH A 301 SITE 6 AC4 24 HOH A 305 HOH A 316 HOH A 320 ALA B 58 SITE 1 AC5 22 GLU C 46 ASN C 50 HIS C 54 GLY C 55 SITE 2 AC5 22 ASP C 81 GLY C 85 ILE C 86 ALA C 92 SITE 3 AC5 22 THR C 98 THR C 99 ARG C 105 SER C 106 SITE 4 AC5 22 GLY C 107 MET C 108 GLY C 109 PHE C 110 SITE 5 AC5 22 THR C 130 MG C 301 HOH C 308 HOH C 315 SITE 6 AC5 22 HOH C 329 ALA D 58 SITE 1 AC6 20 GLU E 46 ASN E 50 ALA E 51 HIS E 54 SITE 2 AC6 20 GLY E 55 ASP E 81 ILE E 86 ALA E 92 SITE 3 AC6 20 THR E 98 THR E 99 ARG E 105 SER E 106 SITE 4 AC6 20 GLY E 107 MET E 108 GLY E 109 PHE E 110 SITE 5 AC6 20 THR E 130 MG E 302 HOH E 318 ALA F 58 CRYST1 115.133 115.133 256.820 90.00 90.00 90.00 P 41 2 2 24 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008686 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008686 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003894 0.00000 MASTER 411 0 6 30 30 0 20 6 0 0 0 66 END